# FOLI BIO INC.: Development of fecal exfoliome sequencing as a multi-omics approach for gut health management

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | FOLI BIO INC. |
| Location | NEW YORK, NY |
| Project | Development of fecal exfoliome sequencing as a multi-omics approach for gut health management |
| Project number | 1R43HG014430-01A1 |
| Mechanism | R43 |
| Institute | National Human Genome Research Institute |
| Award | $399,875 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-18 to 2027-08-31 |
| UEI | MXWVDZNBK5L1 |

## Why this score
- Award of $399,875.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11314303). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.